信息搜索
信息关键字:应
 

共有4161条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209]

·配电物联网应用再获推广助力新一代电力系统建设2019-7-24 22:23:32
·辅仁药业回应分红“放鸽子”:目前现金1.27亿元仅377万未受限2019-7-24 22:11:09
·*ST雏鹰因与供应商拟成立子公司收到关注函2019-7-24 21:03:57
·南方水泥总裁肖家祥:多举措应对进口熟料对国内市场的冲击2019-7-24 17:48:50
·TCL回应并购日本JDI传闻:进行了交流暂无一致性意向和协议2019-7-24 17:10:53
·TCL回应拟并购日本JDI传闻:进行了交流暂无一致性意向和协议2019-7-24 17:10:04
·TCL回应拟并购日本JDI传闻:进行了交流暂无一致性意向和协议2019-7-24 17:09:36
·白皮书:人工智能、量子信息等前沿科技加速应用于军事领域2019-7-24 13:36:50
·泰禾集团回应:与中诚信托不存在借款纠纷2019-7-24 13:32:39
·王静年薪430万元探路者回应称合规2019-7-24 9:55:03
·抛开科创板投机性一面,我们应该用怎样的眼光分析科创板?2019-7-24 9:13:23
·赚钱效应激发入市热情基金加大转债配置力度2019-7-24 7:28:54
·遭质疑市值短期蒸发逾90亿大族激光回应称项目资金未被挪用2019-7-24 3:59:47
·证券类私募头部效应加大22家机构管理规模近9000亿元2019-7-24 0:34:45
·中煤协:全国煤炭应急供应保障难度加大2019-7-23 23:15:50
·揭秘科创板首日投资者行动(下):多家券商客户开通科创板热情高涨,交易系统更是轻松应对!2019-7-23 22:53:55
·刚取消巴菲特午餐的90后涉黄涉赌?回应来了!2019-7-23 22:49:49
·3000万的巴菲特午餐见面会黄了?因病取消还是涉黄、涉赌?孙宇晨这样回应…2019-7-23 22:11:47
·钼市场供应持续紧张钼价近期强势拉涨2019-7-23 21:22:59
·正式回应研发费用资本化问题微芯生物:将予以费用化调整2019-7-23 20:25:42

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209]